News
QDEL
39.68
-2.15%
-0.87
Analysts Estimate QuidelOrtho (QDEL) to Report a Decline in Earnings: What to Look Out for
NASDAQ · 8h ago
QDEL Investors With Large Losses Should Contact Robbins LLP for Information About Their Rights in Connection With the QuidelOrtho Corporation Lawsuit
Robbins LLP reminds investors that a shareholder filed a class action on behalf of QuidelOrtho Corporation stockholders. Robbins LLP is Investigating the Allegations that Quidel ortho misled investors regarding demand for its product. Quidelortho provides tests for the detection and diagnosis of various respiratory diseases.
Barchart · 1d ago
Weekly Report: what happened at QDEL last week (0422-0426)?
Weekly Report · 2d ago
QUIDELORTHO CORPORATION <QDEL.O> : CRAIG-HALLUM CUTS TARGET PRICE TO $40 FROM $50
Reuters · 04/22 16:56
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation. - QDEL
Pomerantz LLP announces that a class action lawsuit has been filed against QuidelOrtho Corporation. Such investors are advised to contact Pomerantz to learn more about the class action. The company's stock has been suspended from the Nasdaq exchange.
Barchart · 04/22 15:06
QuidelOrtho Corporation (QDEL) Investor Notice: Robbins LLP Reminds Stockholders of the QuidelOrtho Corporation Shareholder Class Action
Robbins LLP reminds investors that a shareholder filed a class action on behalf of QuidelOrtho Corporation stockholders. Robbins LLP is investigating allegations that Quidel ortho misled investors regarding demand for its product. Quidelortho provides tests for the detection and diagnosis of various respiratory diseases.
Barchart · 04/22 13:58
Weekly Report: what happened at QDEL last week (0415-0419)?
Weekly Report · 04/22 09:23
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
Glancy Prongay & Murray LLP reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action. Investors who purchased or otherwise acquired QuidelOrtho Corporation common stock between February 18, 2022 and April 1, 2024 may be entitled to a class action lawsuit. The complaint alleges Quidel ortho made materially false and/or misleading statements.
Barchart · 04/19 11:45
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
Rosen Law Firm announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation. If you wish to serve as lead plaintiff, you must move the Court no later than June 11, 2024. A class action suit has already been filed.
Barchart · 04/18 18:30
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against QuidelOrtho Corporation (QDEL)
Law Offices of Howard G. Smith reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the case. Investors who purchased QuidelOrtho Corporation stock between February 18, 2022 and April 1, 2024 are encouraged to contact the firm. The lawsuit alleges that Quidel ortho made materially false and/or misleading statements.
Barchart · 04/18 11:54
QuidelOrtho Enters Oversold Territory (QDEL)
NASDAQ · 04/17 20:21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
A class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation common stock between February 18, 2022 and April 1, 2024. GPM says the company made materially false and misleading statements. Investors have until June 11, 2024 to file a lead plaintiff motion.
Barchart · 04/17 13:09
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
The Law Offices of Frank R. Cruz announces a class action lawsuit has been filed on behalf of investors in QuidelOrtho Corporation. The lawsuit was filed against the Company for allegedly making false and/or misleading statements. Investors have until June 11, 2024 to file a lead plaintiff motion.
Barchart · 04/17 11:15
Press Release: QuidelOrtho To Report First Quarter 2024 Financial Results
QuidelOrtho To Report First Quarter 2024 Financial Results on May 8, 2024. The company will report its financial results for its first quarter ended March 31, 2024, after the market close on Wednesday, May 8. A conference call will be held following the release of the financial results. Quidel ortho is a global provider of innovative in vitro diagnostic technologies.
Dow Jones · 04/17 11:07
QuidelOrtho To Report First Quarter 2024 Financial Results
QuidelOrtho Corporation will report its financial results for its first quarter ended March 31, 2024, after the market close on May 8, 2024. The company will hold a conference call following the release of the financial results. Quidel ortho is a global provider of innovative in vitro diagnostic technologies.
Barchart · 04/17 06:00
Class Action Filed Against QuidelOrtho Corporation f/k/a Quidel Corporation (QDEL) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP
TipRanks · 04/16 16:10
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation (QDEL) Investors
Law Offices of Howard G. Smith announces a class action lawsuit has been filed on behalf of investors who purchased QuidelOrtho Corporation common stock between February 18, 2022 and April 1, 2024. Investors have until June 11, 2024 to file a lead plaintiff motion. The lawsuit alleges that Quidel ortho made false and/or misleading statements.
Barchart · 04/16 13:55
Benjamin Graham Detailed Fundamental Analysis - QDEL
NASDAQ · 04/15 20:06
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – QDEL
Rosen Law Firm announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation (NASDAQ: QDEL) between February 18, 2022 and April 1, 2024. If you purchased common stock during the Class Period you may be entitled to compensation. The lawsuit claims defendants made false and/or misleading statements. A class action has already been filed.
Barchart · 04/15 11:13
Weekly Report: what happened at QDEL last week (0408-0412)?
Weekly Report · 04/15 09:22
More
Webull provides a variety of real-time QDEL stock news. You can receive the latest news about Quidel through multiple platforms. This information may help you make smarter investment decisions.
About QDEL
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.